<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Leng K</submitter><funding>New York Stem Cell Foundation</funding><funding>NEI NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Eye Institute</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Neurological Disorders and Stroke</funding><funding>National Multiple Sclerosis Society</funding><funding>NIA NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute on Aging</funding><funding>NINDS NIH HHS</funding><funding>California Institute for Regenerative Medicine</funding><funding>Chan Zuckerberg Initiative Ben Barres Early Career Acceleration Award</funding><pagination>1528-1542</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9633461</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(11)</volume><pubmed_abstract>Astrocytes become reactive in response to insults to the central nervous system by adopting context-specific cellular signatures and outputs, but a systematic understanding of the underlying molecular mechanisms is lacking. In this study, we developed CRISPR interference screening in human induced pluripotent stem cell-derived astrocytes coupled to single-cell transcriptomics to systematically interrogate cytokine-induced inflammatory astrocyte reactivity. We found that autocrine-paracrine IL-6 and interferon signaling downstream of canonical NF-κB activation drove two distinct inflammatory reactive signatures, one promoted by STAT3 and the other inhibited by STAT3. These signatures overlapped with those observed in other experimental contexts, including mouse models, and their markers were upregulated in human brains in Alzheimer's disease and hypoxic-ischemic encephalopathy. Furthermore, we validated that markers of these signatures were regulated by STAT3 in vivo using a mouse model of neuroinflammation. These results and the platform that we established have the potential to guide the development of therapeutics to selectively modulate different aspects of inflammatory astrocyte reactivity.</pubmed_abstract><journal>Nature neuroscience</journal><pubmed_title>CRISPRi screens in human iPSC-derived astrocytes elucidate regulators of distinct inflammatory reactive states.</pubmed_title><pmcid>PMC9633461</pmcid><funding_grant_id>Druckenmiller Fellowship</funding_grant_id><funding_grant_id>P30 EY002162</funding_grant_id><funding_grant_id>R21 NS119954</funding_grant_id><funding_grant_id>P30 AG066514</funding_grant_id><funding_grant_id>P30 EY02162-39</funding_grant_id><funding_grant_id>R03 AG063157</funding_grant_id><funding_grant_id>R01 NS084030</funding_grant_id><funding_grant_id>Harry Weaver Neuroscience Scholarship</funding_grant_id><funding_grant_id>R01 NS09755</funding_grant_id><funding_grant_id>T32 NS115706</funding_grant_id><funding_grant_id>EDUC4-12812</funding_grant_id><funding_grant_id>K01 AG062683</funding_grant_id><funding_grant_id>P01 NS083513</funding_grant_id><funding_grant_id>F30 AG066418</funding_grant_id><funding_grant_id>R01 NS097551</funding_grant_id><pubmed_authors>Kim H</pubmed_authors><pubmed_authors>Li E</pubmed_authors><pubmed_authors>Krawczyk M</pubmed_authors><pubmed_authors>Ullian EM</pubmed_authors><pubmed_authors>Fancy SPJ</pubmed_authors><pubmed_authors>Rooney B</pubmed_authors><pubmed_authors>Koontz M</pubmed_authors><pubmed_authors>Kampmann M</pubmed_authors><pubmed_authors>Leng K</pubmed_authors><pubmed_authors>Xia W</pubmed_authors><pubmed_authors>Sofroniew MV</pubmed_authors><pubmed_authors>Romero-Fernandez W</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Ao Y</pubmed_authors><pubmed_authors>Goate A</pubmed_authors><pubmed_authors>Lippmann ES</pubmed_authors><pubmed_authors>Tcw J</pubmed_authors><pubmed_authors>Schrag MS</pubmed_authors><pubmed_authors>Rose IVL</pubmed_authors></additional><is_claimable>false</is_claimable><name>CRISPRi screens in human iPSC-derived astrocytes elucidate regulators of distinct inflammatory reactive states.</name><description>Astrocytes become reactive in response to insults to the central nervous system by adopting context-specific cellular signatures and outputs, but a systematic understanding of the underlying molecular mechanisms is lacking. In this study, we developed CRISPR interference screening in human induced pluripotent stem cell-derived astrocytes coupled to single-cell transcriptomics to systematically interrogate cytokine-induced inflammatory astrocyte reactivity. We found that autocrine-paracrine IL-6 and interferon signaling downstream of canonical NF-κB activation drove two distinct inflammatory reactive signatures, one promoted by STAT3 and the other inhibited by STAT3. These signatures overlapped with those observed in other experimental contexts, including mouse models, and their markers were upregulated in human brains in Alzheimer's disease and hypoxic-ischemic encephalopathy. Furthermore, we validated that markers of these signatures were regulated by STAT3 in vivo using a mouse model of neuroinflammation. These results and the platform that we established have the potential to guide the development of therapeutics to selectively modulate different aspects of inflammatory astrocyte reactivity.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2026-05-27T10:52:04.381Z</modification><creation>2025-04-04T11:26:27.216Z</creation></dates><accession>S-EPMC9633461</accession><cross_references><pubmed>36303069</pubmed><doi>10.1038/s41593-022-01180-9</doi></cross_references></HashMap>